Haim Danenberg, MD

Head of interventional cardiology
Wolfson Medical Center
Holon, Israel

Haim Danenberg is an Associate Professor of Medicine in the Hebrew University of Jerusalem, Israel and the head of Interventional Cardiology at Hadassah Medical Center. Dr. Danenberg serves as the Chairman of the Israeli Interventional Workgroup, his main research interests are innovation in structural heart therapy and decision making in interventional cardiology.

Presentation(s):

• VALVE COMPLICATIONS AND MANAGEMENT | SESSION TWO

  Saturday, February 25, 2023
  3:30 PM – 4:30 PM ET

  Disclosure(s): Abbott: Educational Grant (Ongoing); Edwards Lifesciences: clinical proctor (Ongoing); Medtronic: clinical proctor (Ongoing); mitralix: Consultant/Advisory Board (Ongoing); Pi-Cardia: Consultant (Ongoing)

• The Medinol IoNir Hybrid Coronary DES System

  Sunday, February 26, 2023
  4:30 PM – 4:38 PM ET

  Disclosure(s): Abbott: Educational Grant (Ongoing); Edwards Lifesciences: clinical proctor (Ongoing); Medtronic: clinical proctor (Ongoing); mitralix: Consultant/Advisory Board (Ongoing); Pi-Cardia: Consultant (Ongoing)

• Discussion: Is there a Role/Need for Bioresorbable and/or Bioadaptor Platforms?

  Sunday, February 26, 2023
  4:54 PM – 5:18 PM ET

  Disclosure(s): Abbott: Educational Grant (Ongoing); Edwards Lifesciences: clinical proctor (Ongoing); Medtronic: clinical proctor (Ongoing); mitralix: Consultant/Advisory Board (Ongoing); Pi-Cardia: Consultant (Ongoing)

• CARDIOTUBE INTERVIEW: Treatment Of Late Paravalvular Regurgitation After Transcatheter Aortic Valve Implantation

  Monday, February 27, 2023
  8:30 AM – 8:40 AM ET

  Disclosure information not submitted.

• Treatment of Late Paravalvular Regurgitation After Transcatheter Aortic Valve Implantation

  Tuesday, February 28, 2023
  8:20 AM – 8:30 AM ET

  Disclosure(s): Abbott: Educational Grant (Ongoing); Edwards Lifesciences: clinical proctor (Ongoing); Medtronic: clinical proctor (Ongoing); mitralix: Consultant/Advisory Board (Ongoing); Pi-Cardia: Consultant (Ongoing)

• SECOND- AND THIRD-GENERATION AORTIC VALVE SYSTEMS NOT APPROVED IN THE US YET

  Tuesday, February 28, 2023
  8:58 AM – 10:30 AM ET

  Disclosure(s): Abbott: Educational Grant (Ongoing); Edwards Lifesciences: clinical proctor (Ongoing); Medtronic: clinical proctor (Ongoing); mitralix: Consultant/Advisory Board (Ongoing); Pi-Cardia: Consultant (Ongoing)

• Panel Discussion | Second- and Third-Generation Aortic Valve Systems not Approved in the US Yet

  Tuesday, February 28, 2023
  10:18 AM – 10:30 AM ET

  Disclosure(s): Abbott: Educational Grant (Ongoing); Edwards Lifesciences: clinical proctor (Ongoing); Medtronic: clinical proctor (Ongoing); mitralix: Consultant/Advisory Board (Ongoing); Pi-Cardia: Consultant (Ongoing)

• Mitralix Chordal Approximation for Tricuspid Insufficiency

  Tuesday, February 28, 2023
  11:50 AM – 11:58 AM ET

  Disclosure(s): Abbott: Educational Grant (Ongoing); Edwards Lifesciences: clinical proctor (Ongoing); Medtronic: clinical proctor (Ongoing); mitralix: Consultant/Advisory Board (Ongoing); Pi-Cardia: Consultant (Ongoing)